🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and tolerability of XL...
Status
Completed
Location
Investigational Site Number
Start Date
2008-08
Trial ID
NCT00704080
Treatments Being Tested
Primary Objective: The purpose of this study was to determine the long ter...
Status
Completed
Location
Investigational Site Number 840010
Start Date
2012-07-20
Trial ID
NCT01587040
The purpose of this study is to determine the safety and tolerability of XL...
Status
Completed
Location
Investigational Site Number 1302
Start Date
2007-06
Trial ID
NCT00485719
Treatments Being Tested
This research trial is testing a combination of two experimental drugs, MSC...
Status
Completed
Location
Pinnacle Oncology Hematology
Start Date
2011-05
Trial ID
NCT01390818
Phase 1 of this study will evaluate the maximum tolerated dose (MTD) of XL1...
Status
Completed
Location
Investigational Site Number 1537
Start Date
2010-06
Trial ID
NCT01082068
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of XL7...
Status
Completed
Location
Investigational Site Number 168983
Start Date
2008-08
Trial ID
NCT00777699
Treatments Being Tested
This is a double blind, randomized, placebo-controlled, 2-arm, Phase 2 tria...
Status
Completed
Location
Research site
Start Date
2013-09-30
Trial ID
NCT01936363
Treatments Being Tested
Primary Objective: \- To evaluate the safety and tolerability of SAR245409...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2012-06
Trial ID
NCT01596270
Treatments Being Tested
Primary Objective: \- To evaluate the efficacy of SAR245409 as determined ...
Status
Completed
Location
Investigational Site Number 840012
Start Date
2011-10
Trial ID
NCT01403636
Treatments Being Tested
Primary Objective: \- To determine the maximum tolerated dose (MTD) and re...
Status
Completed
Location
Investigational Site Number 840004
Start Date
2011-12
Trial ID
NCT01410513
Treatments Being Tested